Nitrazolam
Benzodiazepine designer drug
From Wikipedia, the free encyclopedia
Nitrazolam is a triazolobenzodiazepine (TBZD) , which are benzodiazepine (BZD) derivatives,[1] that has been sold online as a designer drug.[2][3]
- CA: Schedule IV
- DE: NpSG (Industrial and scientific use only)
- UK: Under Psychoactive Substances Act
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H13N5O2 |
| Molar mass | 319.324 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
It is closely related to clonazolam or flunitrazolam, only differing by the removal of a chlorine or fluorine group respectively at the benzene ring.
A study in mice indicated that nitrazolam can be several times more potent than diazepam as an antagonist of electroshock-induced tonic-extensor convulsions but less potent than diazepam at preventing the righting reflex.[4]
Nitrazolam has been used as an example compound to demonstrate the microscale synthesis of reference materials utilizing polymer‐supported reagents.[5]
Legal status
United Kingdom
In the UK, nitrazolam has been classified as a Class C drug by the May 2017 amendment to The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs.[6]
See also
- Adinazolam
- Alprazolam (licensed)
- Flubromazolam
- Nifoxipam
- Nitemazepam
- Pyrazolam
- Triazolam (licensed)